| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Experimental and Clinical Pharmacology and Toxicology (Drs. Barz, Hummel, and Kobal), and the Department of Neurology(Drs. Pauli, Majer, and Lang), University of Erlangen-Nürnberg, Erlangen, Germany; and the Smell and Taste Center (Dr. Hummel), Department of Otorhinolaryngology, University of Pennsylvania, Philadelphia, PA.
Address correspondence and reprint requests to Dr. Thomas Hummel, Smell and Taste Center, Department of Otorhinolaryngology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104.
Decrease of olfactory function in patients with Parkinson's disease (PD) has been reported by several authors. The current study investigated olfaction in PD patients using olfactory event-related potentials (OERPs) as an electrophysiologic correlate of olfactory function in combination with psychophysical testing. A specific focus was the influence of antiparkinsonian drugs. We investigated PD patients treated with antiparkinsonian drugs (n = 13) and PD patients who received no pharmacologic treatment (n = 18). They were compared to age- and sex-matched control subjects (n = 38). To obtain OERPs, stimulants were chosen to stimulate specifically the olfactory nerve(2.1 ppm vanillin, 0.8 ppm H2S). In addition, chemosomatosensory event-related potentials were recorded after trigeminal stimulation with 52% v/v CO2. Moreover, the subjects' ability to identify and to discriminate odorants was tested by means of a "squeeze bottle" technique. The study yielded the following major results: (1) Odor identification was impaired in PD patients. It was not influenced by treatment with antiparkinsonian drugs. (2) The OERP latencies were prolonged in both PD patients taking and not taking antiparkinsonian drugs; however, this effect was more pronounced in PD patients taking antiparkinsonian drugs.(3) The intranasal chemosensory trigeminal system seemingly was neither affected by the neuronal degeneration seen in PD nor by treatment with antiparkinsonian drugs.
Supported by DFG grant Ko812/5-1, Germany, and grant P01 DC 00161 from the National Institute on Deafness and Other Communication Disorders, National Institutes of Health. Also supported by Schering, Berlin; Sandoz, Nürnberg; and Knoll, Ludwigshafen (Germany).
Received April 25, 1997. Accepted in final form June 14, 1997.
This article has been cited by other articles:
|
|
 |
|
  J. M. Peters, T. Hummel, T. Kratzsch, J. Lotsch, C. Skarke, and L. Frolich Olfactory Function in Mild Cognitive Impairment and Alzheimer's Disease: An Investigation Using Psychophysical and Electrophysiological Techniques Am J Psychiatry, November 1, 2003; 160(11): 1995 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Shusterman and P.C. Avila Real-time Monitoring of Nasal Mucosal pH During Carbon Dioxide Stimulation: Implications for Stimulus Dynamics Chem Senses, September 1, 2003; 28(7): 595 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Shusterman Individual Factors in Nasal Chemesthesis Chem Senses, July 1, 2002; 27(6): 551 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sobel, M. E. Thomason, I. Stappen, C. M. Tanner, J. W. Tetrud, J. M. Bower, E. V. Sullivan, and J. D. E. Gabrieli An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease PNAS, March 16, 2001; (2001) 71061598. [Abstract] [Full Text]
|
|
|
|
 |
|
 C.H. Hawkes, B.C. Shephard, and S.E. Daniel Is Parkinson's disease a primary olfactory disorder? QJM, August 1, 1999; 92(8): 473 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sobel, M. E. Thomason, I. Stappen, C. M. Tanner, J. W. Tetrud, J. M. Bower, E. V. Sullivan, and J. D. E. Gabrieli An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease PNAS, March 27, 2001; 98(7): 4154 - 4159. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
